Is mucoid degeneration of the anterior cruciate ligament associated with osteoarthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mucoid Degeneration of the ACL is Associated with Osteoarthritis

Yes, mucoid degeneration of the anterior cruciate ligament (MD-ACL) is definitively associated with knee osteoarthritis, both as a consequence of existing OA and as a predictor of incident OA development. The relationship is bidirectional and clinically significant.

The Evidence for Association

The most compelling recent evidence comes from a 2024 nested case-control study from the Osteoarthritis Initiative, which demonstrated that ACL signal intensity alteration (a marker of mucoid degeneration) is significantly associated with increased odds of incident knee OA over 4 years 1. This study found that the more severe the ACL signal intensity alteration, the stronger the relationship with KOA occurrence—establishing MD-ACL as a predictor rather than merely a consequence.

A 2025 histological study confirmed that high signal intensity on MRI positively correlates with advanced mucoid degeneration (rs = 0.59-0.62, p < 0.01), and that preoperative MRI can effectively predict the severity of ACL degeneration in OA patients 2. This validates MRI as a reliable tool for detecting this association.

Clinical Manifestations Differ by OA Status

The presentation of MD-ACL varies depending on whether osteoarthritis is present 3:

  • In non-OA patients with MD-ACL: Pain is most commonly located in the posterior knee (43.9%), with pain on terminal flexion being the dominant characteristic (73.1%). These patients have a narrower intercondylar notch width index (0.25 ± 0.03).

  • In OA patients with MD-ACL: Pain shifts to the medial knee (53.8%), though terminal flexion pain remains common (53.8%). The intercondylar notch is wider (0.28 ± 0.02) compared to non-OA MD-ACL patients.

Both groups share a larger posterior tibial slope compared to controls (11.3° vs 9.2°, p < 0.001) 3.

Impact on Surgical Outcomes

MD-ACL development after high tibial osteotomy (HTO) predicts worse intermediate-term outcomes 4. At mean 72.5-month follow-up, patients who developed MD-ACL after HTO showed:

  • Significantly worse IKDC scores (61.0 vs 68.8, p = 0.020)
  • Lower KOOS pain scores (70.1 vs 78.6, p = 0.023)
  • Progressive deterioration over time (IKDC declining from 61.0 to 57.4, p = 0.025)

Risk factors for MD-ACL development post-HTO include:

  • Smaller intercondylar notch geometry (p = 0.003)
  • Increased postoperative medial proximal tibial angle (p = 0.031)
  • Larger changes in posterior tibial slope (p = 0.004)

Pathophysiological Mechanism

The underlying mechanism involves denatured aggrecan accumulation within the ligament matrix due to impaired matrix turnover and interstitial fluid drainage 5. This process:

  • Impairs cruciate ligament integrity
  • Alters viscoelasticity
  • Potentially accelerates both OA progression and meniscal damage

The absence of synovial lining around the ACL is associated with more severe degeneration and may accelerate degenerative changes 2.

Clinical Implications

When evaluating patients with knee OA and deep flexion pain, actively look for MD-ACL on MRI. High signal intensity on T2-weighted images indicates advanced mucoid degeneration and correlates with symptom severity 2.

For patients with confirmed MD-ACL and advanced OA presenting with deep knee pain on flexion, image-guided steroid-bupivacaine injection of the ACL sleeve can provide symptom resolution lasting 6-15 months (mean 8 months), potentially deferring knee replacement surgery 6.

Important Caveats

While major guidelines on ACL injuries 7 and post-traumatic knee OA 8 acknowledge that ACL tears and associated injuries increase OA risk, they do not specifically address non-traumatic mucoid degeneration as a distinct entity. The moderate-certainty evidence from these guidelines focuses on traumatic injuries, multistructure damage, and meniscal involvement as OA risk factors 8.

The research evidence clearly establishes MD-ACL as both a marker and predictor of OA, but this represents an evolving understanding not yet fully incorporated into major clinical practice guidelines. In clinical practice, treat MD-ACL as a significant pathological finding that warrants attention in OA management, particularly when patients report deep flexion pain.

References

Research

Predicting anterior cruciate ligament degeneration using magnetic resonance imaging: Insights from histological evaluation.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2025

Related Questions

In a patient with sudden sharp pain in the right buttock and hip on hip movement, and an X‑ray showing only grade I osteoarthritis, which nerve is likely being irritated?
What is the recommended management for a 59-year-old with mild early medial compartment osteoarthritis of the right knee?
What are the symptoms of hip osteoarthritis and how should it be managed?
What are the preoperative preparation steps and eligibility criteria for total hip replacement (THR) in a geriatric patient (≥65 years) with hip osteoarthritis, including required medical optimization, medication management, cardiac and pulmonary assessment, nutritional status, bone health, cognitive screening, and functional considerations?
I have left ankle pain and an effusive right knee with moderate tricompartmental osteoarthritis; could the knee be the primary pain generator and what evaluation and treatment do you recommend?
Which β3‑adrenergic agonist is preferred over mirabegron for treating overactive bladder in a patient with urinary incontinence and constipation?
How should an equivocal stress electrocardiogram be interpreted when the accompanying stress echocardiogram shows no wall‑motion abnormalities?
What is the recommended management for thoracic outlet syndrome?
In a patient with left foot numbness and weakness who can dorsiflex the foot but has reduced strength compared to the right and no complete foot drop, should additional neurologic workup (e.g., lumbar spine MRI and electrodiagnostic studies) be performed at this time?
What is the interpretation of an equivocal stress electrocardiogram for ischemia with a normal resting two‑dimensional echocardiogram showing no regional wall‑motion abnormalities?
What is the interpretation of this urinalysis showing yellow‑straw clear urine, specific gravity 1.015, pH 6.0, leukocyte esterase 500 + (positive), nitrite negative, protein 1 + (positive), ketones 1 + (positive), urobilinogen 2 + (elevated), blood 2 + (positive), red blood cells 21‑50 per high‑power field (HPF), white blood cells too numerous to count per high‑power field (HPF), and bacteria 2 + (positive)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.